Industry news

• New WHO guidance to support manufacturers to reduce AMR risk

  05 September 2024 Catherine Eckford / European Pharmaceutical Review

  The recommendations offered in the guidance is applicable across different areas of manufacturing, from active pharmaceutical ingredients (APIs), through to formulation and packaging.

• Russian Direct Investment Fund to assist localization of Russian pharmaceutical production in Mongolia

  05 September 2024 GxP news

  The Russian Direct Investment Fund (RDIF) and the Mongolian pharmaceutical company MEIC have agreed to cooperate in this area. The partnership includes collaborative investments in initiatives to transfer technology and localize the production of Russian pharmaceuticals in Mongolia.

• Streamlining Prior Authorizations and Unlocking Patient Access to Specialty Medications

  04 September 2024 FiercePharma

  When Marie D'Orsaneo's rheumatoid arthritis worsened, her doctor prescribed Rituxan, a pricey injectable medication. But her health plan’s approval process dragged on, turning days into weeks. As she waited, her condition deteriorated, forcing her to quit her job, move in with relatives, and seek inpatient care.

• Sobyanin: “National project boosted bionic prostheses’ production by 20%”

  03 September 2024 GxP news

  Moscow Mayor Sergey Sobyanin said Motorika’s involvement in the “Labor Productivity” project led to a 20% increase in bionic prostheses’ production, 16% reduced assembly time, and 33% reduction in unused materials. Thus, the economic effect of the company’s participation exceeded 100 million rubles.

• FDA's drug center to consolidate AI efforts under single council

  03 September 2024 FiercePharma

  The FDA’s Center for Drug Evaluation and Research (CDER) is consolidating its artificial-intelligence-related activities under a single AI Council, in part in response to efforts from the Biden administration to ensure the safety and security of machine learning software.

• Two Russian universities agreed to develop medicinal products from plant materials

  02 September 2024 GxP news

  The Siberian State Medical University (SSMU) and the Buryat State Agricultural Academy (BSAA) Named After V.R. Filippov have entered into a collaboration focused on the processing of medicinal plants. Through this partnership, the institutions aim to advance research and development in herbal medicine.

• Moscow’s drug and medical device production up 9.8% this year

  02 September 2024 GxP news

  The production of medicines and medical devices in Moscow has seen a 9.8% increase from January to June 2024 compared to the same period last year, according to Deputy Mayor Maxim Liksutov. Notably, the production of pharmaceutical substances surged by over 2.6 times during this timeframe. However, the six-month growth rate showed a slight decrease when compared to the January-May 2024 period, where medicine production had risen by 12.7% and pharmaceutical substances by more than 2.8 times.

• Russian drug against monkeypox shows effectiveness

  02 September 2024 GxP news

  The drug NIOH-14, developed by employees of the Vorozhtsov Novosibirsk Institute of Organic Chemistry and the State Scientific Center of Virology and Biotechnology “Vector” , has proven effective in preventing infection with monkeypox (mpox). This is the first chemical drug in Russia for the treatment and emergency prevention of smallpox and other orthopoxvirus diseases in humans.

• Plasma centers will be installed in Perm and Ivanovo

  02 September 2024 GxP news

  Rosplasma is looking for a contractor to procure medical modules for the establishment of cutting-edge, air-conditioned plasma centers in Perm and Ivanovo. These centers will act as central locations for gathering, processing, and temporarily storing human plasma, which will then be distributed for fractionation. The initial stated price is 518.7 million rubles.

• Sobyanin: “National project boosted bionic prostheses’ production by 20%”

  30 August 2024 GxP news

  Moscow Mayor Sergey Sobyanin said Motorika’s involvement in the “Labor Productivity” project led to a 20% increase in bionic prostheses’ production, 16% reduced assembly time, and 33% reduction in unused materials. Thus, the economic effect of the company’s participation exceeded 100 million rubles.